The Cost-Effectiveness of Subcutaneous Semaglutide Versus Empagliflozin in Type 2 Diabetes Uncontrolled on Metformin Alone in Denmark
Ehlers, Lars H., Lamotte, Mark, Ramos, Mafalda C., Sandgaard, Susanne, Holmgaard, Pia, Kristensen, Malene M., Ejskjaer, Niels
Published in Diabetes therapy (01.03.2022)
Published in Diabetes therapy (01.03.2022)
Get full text
Journal Article
The cost–effectiveness of oral semaglutide versus empagliflozin in Type 2 diabetes in Denmark
Ehlers, Lars H, Lamotte, Mark, Ramos, Mafalda C, Sandgaard, Susanne, Holmgaard, Pia, Frary, Evan C, Ejskjaer, Niels
Published in Journal of comparative effectiveness research (01.01.2022)
Published in Journal of comparative effectiveness research (01.01.2022)
Get full text
Journal Article